906 related articles for article (PubMed ID: 29244806)
1. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
Hammond SL; Leek AN; Richman EH; Tjalkens RB
PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
[TBL] [Abstract][Full Text] [Related]
3. Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection.
McLean JR; Smith GA; Rocha EM; Hayes MA; Beagan JA; Hallett PJ; Isacson O
Neurosci Lett; 2014 Jul; 576():73-8. PubMed ID: 24882721
[TBL] [Abstract][Full Text] [Related]
4. Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice.
Gholizadeh S; Tharmalingam S; Macaldaz ME; Hampson DR
Hum Gene Ther Methods; 2013 Aug; 24(4):205-13. PubMed ID: 23808551
[TBL] [Abstract][Full Text] [Related]
5. Systemic application of AAV vectors targeting GFAP-expressing astrocytes in Z-Q175-KI Huntington's disease mice.
Vagner T; Dvorzhak A; Wójtowicz AM; Harms C; Grantyn R
Mol Cell Neurosci; 2016 Dec; 77():76-86. PubMed ID: 27989734
[TBL] [Abstract][Full Text] [Related]
6. Targeted gene delivery to the enteric nervous system using AAV: a comparison across serotypes and capsid mutants.
Benskey MJ; Kuhn NC; Galligan JJ; Garcia J; Boye SE; Hauswirth WW; Mueller C; Boye SL; Manfredsson FP
Mol Ther; 2015 Mar; 23(3):488-500. PubMed ID: 25592336
[TBL] [Abstract][Full Text] [Related]
7. Vector serotype screening for use in ovine perinatal lung gene therapy.
McClain LE; Davey MG; Zoltick PW; Limberis MP; Flake AW; Peranteau WH
J Pediatr Surg; 2016 Jun; 51(6):879-84. PubMed ID: 27032612
[TBL] [Abstract][Full Text] [Related]
8. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.
Burger C; Gorbatyuk OS; Velardo MJ; Peden CS; Williams P; Zolotukhin S; Reier PJ; Mandel RJ; Muzyczka N
Mol Ther; 2004 Aug; 10(2):302-17. PubMed ID: 15294177
[TBL] [Abstract][Full Text] [Related]
9. Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain.
Markakis EA; Vives KP; Bober J; Leichtle S; Leranth C; Beecham J; Elsworth JD; Roth RH; Samulski RJ; Redmond DE
Mol Ther; 2010 Mar; 18(3):588-93. PubMed ID: 20010918
[TBL] [Abstract][Full Text] [Related]
10. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
[TBL] [Abstract][Full Text] [Related]
11. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
[TBL] [Abstract][Full Text] [Related]
12. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector.
Rincon MY; de Vin F; Duqué SI; Fripont S; Castaldo SA; Bouhuijzen-Wenger J; Holt MG
Gene Ther; 2018 Apr; 25(2):83-92. PubMed ID: 29523880
[TBL] [Abstract][Full Text] [Related]
13. Intracerebroventricular injection of adeno-associated virus 6 and 9 vectors for cell type-specific transgene expression in the spinal cord.
Dirren E; Towne CL; Setola V; Redmond DE; Schneider BL; Aebischer P
Hum Gene Ther; 2014 Feb; 25(2):109-20. PubMed ID: 24191919
[TBL] [Abstract][Full Text] [Related]
14. Specific AAV serotypes stably transduce primary hippocampal and cortical cultures with high efficiency and low toxicity.
Royo NC; Vandenberghe LH; Ma JY; Hauspurg A; Yu L; Maronski M; Johnston J; Dichter MA; Wilson JM; Watson DJ
Brain Res; 2008 Jan; 1190():15-22. PubMed ID: 18054899
[TBL] [Abstract][Full Text] [Related]
15. Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.
Woodard KT; Liang KJ; Bennett WC; Samulski RJ
J Virol; 2016 Nov; 90(21):9878-9888. PubMed ID: 27558418
[TBL] [Abstract][Full Text] [Related]
16. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
Janelidze S; Nordström U; Kügler S; Brundin P
J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
[TBL] [Abstract][Full Text] [Related]
17. Intracerebroventricular Administration of AAV9-PHP.B SYN1-EmGFP Induces Widespread Transgene Expression in the Mouse and Monkey Central Nervous System.
Galvan A; Petkau TL; Hill AM; Korecki AJ; Lu G; Choi D; Rahman K; Simpson EM; Leavitt BR; Smith Y
Hum Gene Ther; 2021 Jun; 32(11-12):599-615. PubMed ID: 33860682
[TBL] [Abstract][Full Text] [Related]
18. Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficient mice.
Passini MA; Watson DJ; Vite CH; Landsburg DJ; Feigenbaum AL; Wolfe JH
J Virol; 2003 Jun; 77(12):7034-40. PubMed ID: 12768022
[TBL] [Abstract][Full Text] [Related]
19. Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain.
Aschauer DF; Kreuz S; Rumpel S
PLoS One; 2013; 8(9):e76310. PubMed ID: 24086725
[TBL] [Abstract][Full Text] [Related]
20. Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins.
Klein RL; Dayton RD; Leidenheimer NJ; Jansen K; Golde TE; Zweig RM
Mol Ther; 2006 Mar; 13(3):517-27. PubMed ID: 16325474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
